$DNLI: The Week Ahead In Biotech: Conferences, Clinical Trials And …

Date: Saturday, December 8th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: Denali Therapeutics Inc (NASDAQ: DNLI) is scheduled to present Phase 1 data for its Alzheimer’s disease candidate DNL747 at its R&D Day Monday, Dec. 10.

Full article address: https://www.benzinga.com/general/biotech/18/12/12807823/the-week-ahead-in-biotech-conferences-clinical-trials-and-earnings

Related News:

$DNLI $EVLO: Flagship Pioneering Expands Growth Capabilities, Announces …

$DNLI $GH $VRA $YETI: Outside the Box: Harry Boxer’s 4 stocks running on earnings

$DNLI: AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi …

$DNLI: Early-stage study of Denali’s Alzheimer’s candidate DNL747 …

$DNLI: Exclusive: Quietly, Gladstone founder’s new company plots unique …

$DNLI: Denali teams up with Sirion in gene therapies

$DNLI: SIRION Biotech and Denali Therapeutics Join Forces to Develop …

$DNLI $EVLO: Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive …

$CWT $CENT $DNLI: Do Hedge Funds Love Atlantica Yield plc (AY)?

$DNLI $EVLO: Therapeutics appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer

$DNLI $SNY: Health Care Digest: Genentech’s blood cancer win, a boost for …

Latest News:

$MO: Why Marlboro Maker Bet on Juul, the Vaping Upstart Aiming to Kill Cigarettes

$MO: CEO Q&A: Altria Boss on Getting Into Weed, Taking Risks

$ABB: Duerr – A Good Play For Digitalization

$ARLO: ARLO 72 HOUR DEADLINE ALERT: Approximately 72 Hours …

$NI: NISOURCE INVESTIGATION INITIATED by Former Louisiana …

$FB: FEMA Officials Accidentally Released Private Data From 2.3 Million Disaster Victims

$AMZN: Is Amazon’s Private-Label Business a Paper Tiger?

$BITA: Auto Sales in China Are Weak, but Bitauto Is Gaining Market Share

$BPI: The Law Offices of Timothy L. Miles Announces Investigation on …

$RUN $VSLR $SPWR: The US Solar Industry Shows Resilience in 2018

$WFC: Sens. Warren, Brown: Boot Wells Fargo CEO